MedPath

Waitlist Controlled Comparison of Cognitive-behavioral vs. Mindfulness-based Online-treatments for Women With Low Sexual Desire

Not Applicable
Completed
Conditions
Hypoactive Sexual Desire Disorder
Registration Number
NCT03780751
Lead Sponsor
Ruhr University of Bochum
Brief Summary

Problems with sexual function are common and distressing. The most frequent sexual difficulty in women is a lack of sexual desire with a prevalence of 20-30%. When low sexual desire is experienced over several months and causes significant personal distress, a sexual dysfunction can be diagnosed (ICD-10: Hypoactive Sexual Desire Disorder: HSDD). A distressing lack of desire is reported by 6% of sexually active women. Psychological interventions are the treatment of choice for women with HSDD. Promising treatment approaches include cognitive-behavioral and mindfulness-based interventions. A recent meta-analysis also showed that Internet-delivered programs are a valid alternative to face-to-face treatments. Aim of this project to assess the effectivity of two eight-week online-programs consisting of cognitive-behavioral (COPE) and mindfulness-based (MIND) interventions for women with HSDD. Both treatments will be compared to a waitlist-control group. For this project, two well-established group-treatment manuals will be translated into German and adapted to a multimedia online-environment. All participants will be guided through the programs by well-qualified eCoaches.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
266
Inclusion Criteria
  • 18 years or older
  • female gender
  • able to read, write and speak German
  • Meet criteria of ICD-10 criteria of Hypoactive Sexual Desire Disorder (established via online-screening and telephone interview)
  • Experience significant sexuality-related personal distress (established via online-screening and telephone interview)
Exclusion Criteria
  • currently pregnant
  • ongoing medical or psychological treatment for low desire or other sexual dysfunctions or plans to enter such treatment (e.g., in-person sexual therapy, couples therapy) during study participation
  • suicide ideation (established via telephone interview)
  • currently experiencing significant symptoms of a mental disorder that might interfere with study participation (e.g., Eating Disorders, Obsessive-Compulsive Disorder, Posttraumatic Stress Disorder, Major Depression, Bipolar Disorder) as established via telephone interview
  • currently experiencing significant symptoms of a physical condition that might interfere with study participation (e.g., cancer, multiple sclerosis) as established via telephone interview
  • current Substance-Abuse Disorder
  • current or lifetime Psychotic Disorder
  • significant relationship discord or violence

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Sexual Interest and Desire Inventory Female (SIDI-F)at baseline, 5 weeks after baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline

The SIDI-F is a clinician-rated instrument consisting of 13 items designed to assess HSDD severity in women. A self-report version, modified for the use in partnered and unpartnered women will be applied.

Secondary Outcome Measures
NameTimeMethod
Female Sexual Distress Scale Revised (FSDS-R)at baseline, 5 weeks after baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline

The Female Sexual Distress Scale (FSDS) is a 13-item self- assessment questionnaire for the evaluation of sexually related personal distress.

Trial Locations

Locations (1)

Ruhr University Bochum

🇩🇪

Bochum, NRW, Germany

Ruhr University Bochum
🇩🇪Bochum, NRW, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.